Abstract
Radiation-induced heart disease (RIHD) is a significant cause of morbidity in breast and other mediastinal cancers. The many molecular and cellular patho-mechanisms that have a role in RIHD are not completely understood. Endothelial injury, oxidative stress, and inflammation, as well as endoplasmic reticulum and mitochondrial damage, are considered the primary causes of RIHD. Ferroptosis is a newly discovered type of cell death that results from irondependent lipid peroxide accumulation. As ferroptosis plays an important role in the pathogenesis of cardiovascular diseases, it seems that it has a significant effect on RIHD. It was recently shown that ionizing radiation (IR) generates severe ferroptosis, which is a critical component of Radiotherapy-mediated normal cell toxicity. These findings support the use of a ferroptosis inhibitor to reduce RIHD. In this perspective review, we summarize the role of ferroptosis in pathogens of cardiovascular disease and radiation toxicity, and we will introduce ferroptosis inhibitors as a new strategy to prevent or reduce RIHD.
Keywords: Ferroptosis, radiotherapy, heart disease, radioprotective, ferrostatin-1, ferroptosis inhibitor.
[http://dx.doi.org/10.1038/493S2a] [PMID: 23364768]
[http://dx.doi.org/10.1161/01.CIR.97.18.1837] [PMID: 9603539]
[http://dx.doi.org/10.3109/09553000903264473] [PMID: 19995235]
[http://dx.doi.org/10.1667/RR2933.1] [PMID: 22663150]
[http://dx.doi.org/10.1093/jrr/rrw064] [PMID: 27422929]
[http://dx.doi.org/10.1001/archinte.1968.03640030022003] [PMID: 5642742]
[http://dx.doi.org/10.1007/s10863-019-09820-9] [PMID: 31853753]
[http://dx.doi.org/10.3389/fcvm.2020.00020] [PMID: 32154269]
[http://dx.doi.org/10.2174/1389203013381107] [PMID: 12369933]
[http://dx.doi.org/10.1021/pr501141b] [PMID: 25590149]
[http://dx.doi.org/10.2174/1389557522666220218123404] [PMID: 35184711]
[http://dx.doi.org/10.1038/s41422-019-0263-3] [PMID: 31949285]
[http://dx.doi.org/10.3389/fcell.2021.675617] [PMID: 34249928]
[http://dx.doi.org/10.3389/fnins.2020.00267] [PMID: 32372896]
[http://dx.doi.org/10.3389/fcvm.2020.00148] [PMID: 33005633]
[http://dx.doi.org/10.3390/biomedicines9121845] [PMID: 34944662]
[http://dx.doi.org/10.1016/j.ejphar.2012.06.037] [PMID: 22771294]
[http://dx.doi.org/10.1002/pmic.201100178] [PMID: 21751382]
[http://dx.doi.org/10.2147/JIR.S307081] [PMID: 34045882]
[http://dx.doi.org/10.1667/RR15486.1] [PMID: 32134361]
[http://dx.doi.org/10.1080/09553002.2021.1876956] [PMID: 33464146]
[http://dx.doi.org/10.3389/fphar.2020.00239] [PMID: 32256352]